Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Aytu BioPharma Inc. (AYTU) had Earnings per Share (EPS) (Basic) of $-2.86 for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
$81.00M |
|
$-15.84M |
|
$26.42M |
|
$54.59M |
|
$86.26M |
|
$-5.25M |
|
$-8.82M |
|
$-14.08M |
|
$-14.08M |
|
$-15.84M |
|
$-15.84M |
|
$-15.84M |
|
$-15.84M |
|
$-5.25M |
|
$3.62M |
|
5.54M |
|
5.54M |
|
|
Earnings per Share (EPS) (Basic) |
$-2.86 |
$-2.86 |
|
| Balance Sheet Financials | |
$61.89M |
|
$0.69M |
|
$56.20M |
|
$118.09M |
|
$62.23M |
|
$10.88M |
|
$28.15M |
|
$90.38M |
|
$27.72M |
|
$-24.74M |
|
$27.72M |
|
5.97M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
$-0.33M |
|
$-1.26M |
|
$22.98M |
|
$20.01M |
|
$-2.98M |
|
$2.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.99 |
|
-- |
|
-- |
|
0.28 |
|
0.55 |
|
67.39% |
|
-6.49% |
|
-6.49% |
|
4.46% |
|
-17.38% |
|
-19.56% |
|
$-1.39M |
|
-- |
|
-- |
|
-- |
|
0.69 |
|
2.09 |
|
3.43 |
|
106.42 |
|
-57.17% |
|
64.05% |
|
-13.42% |
|
-41.05% |
|
$4.64 |
|
$-0.25 |
|
$-0.25 |
|